{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:25Z","timestamp":1759336345779,"version":"3.44.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PZ00P3_179919"],"award-info":[{"award-number":["PZ00P3_179919"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Swiss Academy of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In the post-pandemic phase, the value of annual SARS-CoV-2 booster vaccination in healthcare-workers is unclear. In this multicentre cohort study, we sought to determine the association of SARS-CoV-2 vaccination status and other risk factors with the occurrence of influenza-like respiratory illness and workdays lost due to influenza-like respiratory illness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>During a period of high SARS-CoV-2 community transmission (November 2023 to May 2024), we collected weekly data on symptoms and sick day leave and used negative binomial regression to identify risk factors for these outcomes among 1745 healthcare workers. To single out the effect of the vaccine and account for potential confounding, additional inverse probability weighted analysis was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In both analyses, we show that more SARS-CoV-2 vaccinations are associated with a higher risk of influenza-like respiratory illness and workdays lost. For influenza-like respiratory illness, the association is stronger with a more recent timing of the vaccination rather than the number of vaccinations, which suggests that the effect wanes over time. In contrast, seasonal influenza vaccination is associated with a decreased risk for both outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Based on our data, we conclude that SARS-CoV-2 booster vaccination does not contribute to the protection of the healthcare workforce in a post-pandemic setting. SARS-CoV-2 vaccination may even temporarily increase the likelihood of symptomatic infection and workday loss.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s43856-025-01046-8","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T15:13:43Z","timestamp":1754752423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6033-1037","authenticated-orcid":false,"given":"Tamara","family":"D\u00f6rr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-8600","authenticated-orcid":false,"given":"Tala","family":"Ballouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Cusini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Gr\u00e4ssli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emina","family":"Kocan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Carsten","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milo A.","family":"Puhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"von Kietzell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"R\u00fctti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-7894","authenticated-orcid":false,"given":"Reto","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Vuichard Gysin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-3276","authenticated-orcid":false,"given":"Christian R.","family":"Kahlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan P.","family":"Kuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-8934","authenticated-orcid":false,"given":"Philipp","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the SURPRISE+ Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Goppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja F.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"Risch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"1046_CR1","unstructured":"World Health Organization. WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1 (2023)."},{"key":"1046_CR2","unstructured":"Swiss Federal Office of Public Health (FOPH). Guidelines and Recommendations for Covid-19 vaccination [German]. https:\/\/backend.bag.admin.ch\/fileservice\/sdweb-docs-prod-bagadminch-files\/files\/2025\/03\/18\/7109ca20-df42-4a90-a84b-9d356f217877.pdf (2023)."},{"key":"1046_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2002083","volume":"18","author":"R Patel","year":"2022","unstructured":"Patel, R., Kaki, M., Potluri, V. S., Kahar, P. & Khanna, D. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Hum. Vaccin Immunother. 18, 2002083 (2022).","journal-title":"Hum. Vaccin Immunother."},{"key":"1046_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.abq1841","volume":"377","author":"CJ Reynolds","year":"2022","unstructured":"Reynolds, C. J. et al. Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure. Science 377, eabq1841 (2022).","journal-title":"Science"},{"key":"1046_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.cell.2022.01.018","volume":"185","author":"K Roltgen","year":"2022","unstructured":"Roltgen, K. et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell 185, 1025\u20131040.e1014 (2022).","journal-title":"Cell"},{"key":"1046_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1473-3099(22)00792-7","volume":"23","author":"M Hoffmann","year":"2023","unstructured":"Hoffmann, M. et al. Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation. Lancet Infect. Dis. 23, 25\u201328 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1046_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/eci.14136","volume":"54","author":"A Chalupka","year":"2024","unstructured":"Chalupka, A. et al. Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria. Eur. J. Clin. Invest 54, e14136 (2024).","journal-title":"Eur. J. Clin. Invest"},{"key":"1046_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh0761","volume":"9","author":"H Chemaitelly","year":"2023","unstructured":"Chemaitelly, H. et al. History of primary-series and booster vaccination and protection against Omicron reinfection. Sci. Adv. 9, eadh0761 (2023).","journal-title":"Sci. Adv."},{"key":"1046_CR9","doi-asserted-by":"publisher","first-page":"e2225320","DOI":"10.1001\/jamanetworkopen.2022.25320","volume":"5","author":"E Eythorsson","year":"2022","unstructured":"Eythorsson, E., Runolfsdottir, H. L., Ingvarsson, R. F., Sigurdsson, M. I. & Palsson, R. Rate of SARS-CoV-2 reinfection during an Omicron wave in Iceland. JAMA Netw. Open 5, e2225320 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1046_CR10","doi-asserted-by":"publisher","first-page":"e074404","DOI":"10.1136\/bmj-2022-074404","volume":"381","author":"S Monge","year":"2023","unstructured":"Monge, S., Pastor-Barriuso, R. & Hernan, M. A. The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies. BMJ 381, e074404 (2023).","journal-title":"BMJ"},{"key":"1046_CR11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.cmi.2021.05.014","volume":"27","author":"CR Kahlert","year":"2021","unstructured":"Kahlert, C. R. et al. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study. Clin. Microbiol. Infect. 27, 1336\u20131344 (2021).","journal-title":"Clin. Microbiol. Infect."},{"key":"1046_CR12","doi-asserted-by":"publisher","first-page":"e1004035","DOI":"10.1371\/journal.pmed.1004035","volume":"19","author":"NL Cobb","year":"2022","unstructured":"Cobb, N. L. et al. Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020. PLoS Med. 19, e1004035 (2022).","journal-title":"PLoS Med."},{"key":"1046_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03351-w","volume":"22","author":"E Dietz","year":"2024","unstructured":"Dietz, E. et al. SARS-CoV-2, influenza A\/B and respiratory syncytial virus positivity and association with influenza-like illness and self-reported symptoms, over the 2022\/23 winter season in the UK: a longitudinal surveillance cohort. BMC Med. 22, 143 (2024).","journal-title":"BMC Med."},{"key":"1046_CR14","unstructured":"Swiss Federal Office of Public Health (FOPH). Infectious Diseases Dashboard: Influenza (Seasonal flu). https:\/\/www.idd.bag.admin.ch\/diseases\/influenza\/overview (2024)."},{"key":"1046_CR15","unstructured":"Centres for Disease Control and Prevention (CDC). U.S. Influenza Surveillance: Purpose and Methods. https:\/\/www.cdc.gov\/fluview\/overview\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/flu\/weekly\/overview.htm (2025)."},{"key":"1046_CR16","unstructured":"European Centre for Disease Prevention and Control (ECDC). Commission implementing decision (EU) 2018\/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Official Journal of the European Union, 2018). https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32018D0945&from=EN#page=24."},{"key":"1046_CR17","first-page":"250","volume":"188","author":"F Li","year":"2019","unstructured":"Li, F., Thomas, L. E. & Li, F. Addressing extreme propensity scores via the overlap weights. Am. J. Epidemiol. 188, 250\u2013257 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"1046_CR18","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/cid\/ciac327","volume":"75","author":"NK Shrestha","year":"2022","unstructured":"Shrestha, N. K. et al. Coronavirus disease 2019 vaccine boosting in previously infected or vaccinated individuals. Clin. Infect. Dis. 75, 2169\u20132177 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1046_CR19","doi-asserted-by":"publisher","unstructured":"Thomas, R. E., Jefferson, T. & Lasserson, T. J. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst. Rev., CD005187 (2010). https:\/\/doi.org\/10.1002\/14651858.CD005187.pub3.","DOI":"10.1002\/14651858.CD005187.pub3"},{"key":"1046_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/vaccines9101104","volume":"9","author":"T Li","year":"2021","unstructured":"Li, T. et al. A systematic review and meta-analysis of seasonal influenza vaccination of health workers. Vaccines 9, 1104 (2021).","journal-title":"Vaccines"},{"key":"1046_CR21","doi-asserted-by":"publisher","first-page":"e0198685","DOI":"10.1371\/journal.pone.0198685","volume":"13","author":"C Imai","year":"2018","unstructured":"Imai, C. et al. A systematic review and meta-analysis of the direct epidemiological and economic effects of seasonal influenza vaccination on healthcare workers. PLoS One 13, e0198685 (2018).","journal-title":"PLoS One"},{"key":"1046_CR22","doi-asserted-by":"publisher","first-page":"e162581","DOI":"10.1172\/JCI162581","volume":"133","author":"DM Murphy","year":"2023","unstructured":"Murphy, D. M. et al. Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine. J. Clin. Invest. 133, e162581 (2023).","journal-title":"J. Clin. Invest."},{"key":"1046_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1242380","volume":"14","author":"A Noe","year":"2023","unstructured":"Noe, A. et al. BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists. Front. Immunol. 14, 1242380 (2023).","journal-title":"Front. Immunol."},{"key":"1046_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","volume":"596","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam, P. S. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596, 410\u2013416 (2021).","journal-title":"Nature"},{"key":"1046_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109762","volume":"255","author":"K Fohse","year":"2023","unstructured":"Fohse, K. et al. The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses. Clin. Immunol. 255, 109762 (2023).","journal-title":"Clin. Immunol."},{"key":"1046_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543\u2013555 (2022).","journal-title":"Nat. Immunol."},{"key":"1046_CR27","doi-asserted-by":"publisher","first-page":"e1010830","DOI":"10.1371\/journal.ppat.1010830","volume":"18","author":"Z Qin","year":"2022","unstructured":"Qin, Z., Bouteau, A., Herbst, C. & Igyarto, B. Z. Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion. PLoS Pathog. 18, e1010830 (2022).","journal-title":"PLoS Pathog."},{"key":"1046_CR28","doi-asserted-by":"publisher","first-page":"e1004125","DOI":"10.1371\/journal.pmed.1004125","volume":"19","author":"B Babouee Flury","year":"2022","unstructured":"Babouee Flury, B. et al. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study. PLoS Med. 19, e1004125 (2022).","journal-title":"PLoS Med."},{"key":"1046_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jinf.2023.06.018","volume":"87","author":"AC Dowell","year":"2023","unstructured":"Dowell, A. C. et al. Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children. J. Infect. 87, 267\u2013269 (2023).","journal-title":"J. Infect."},{"key":"1046_CR30","doi-asserted-by":"publisher","first-page":"e074325","DOI":"10.1136\/bmj-2022-074325","volume":"382","author":"NW Andersson","year":"2023","unstructured":"Andersson, N. W. et al. Comparative effectiveness of heterologous third dose vaccine schedules against severe COVID-19 during omicron predominance in Nordic countries: population based cohort analyses. BMJ 382, e074325 (2023).","journal-title":"BMJ"},{"key":"1046_CR31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40273-022-01224-9","volume":"41","author":"MH Blanchet Zumofen","year":"2023","unstructured":"Blanchet Zumofen, M. H., Frimpter, J. & Hansen, S. A. Impact of Influenza and Influenza-Like Illness on Work Productivity Outcomes: A Systematic Literature Review. Pharmacoeconomics 41, 253\u2013273 (2023).","journal-title":"Pharmacoeconomics"},{"key":"1046_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1017\/ice.2020.444","volume":"42","author":"SP Kuster","year":"2021","unstructured":"Kuster, S. P. et al. Absenteeism and presenteeism in healthcare workers due to respiratory illness. Infect. Control Hosp. Epidemiol. 42, 268\u2013273 (2021).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"1046_CR33","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1017\/ice.2023.47","volume":"44","author":"K Linsenmeyer","year":"2023","unstructured":"Linsenmeyer, K. et al. Sickness presenteeism in healthcare workers during the coronavirus disease 2019 (COVID-19) pandemic: An observational cohort study. Infect. Control Hosp. Epidemiol. 44, 1693\u20131696 (2023).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"1046_CR34","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.ajic.2017.04.008","volume":"45","author":"S Chiu","year":"2017","unstructured":"Chiu, S. et al. Working with influenza-like illness: Presenteeism among US health care personnel during the 2014-2015 influenza season. Am. J. Infect. Control 45, 1254\u20131258 (2017).","journal-title":"Am. J. Infect. Control"},{"key":"1046_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39113-6","volume":"13","author":"KA Peter","year":"2023","unstructured":"Peter, K. A. et al. Extent and predictors of presenteeism among healthcare professionals working in Swiss hospitals, nursing homes and home care organizations. Sci. Rep. 13, 12042 (2023).","journal-title":"Sci. Rep."},{"key":"1046_CR36","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1017\/ice.2020.1396","volume":"42","author":"D Hoang Johnson","year":"2021","unstructured":"Hoang Johnson, D. et al. Barriers and facilitators to influenza-like illness absenteeism among healthcare workers in a tertiary-care healthcare system, 2017-2018 influenza season. Infect. Control Hosp. Epidemiol. 42, 1198\u20131205 (2021).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"1046_CR37","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s10096-014-2119-6","volume":"33","author":"R Huttunen","year":"2014","unstructured":"Huttunen, R. & Syrjanen, J. Healthcare workers as vectors of infectious diseases. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1477\u20131488 (2014).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"1046_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archinternmed.2010.500","volume":"171","author":"P Vanhems","year":"2011","unstructured":"Vanhems, P. et al. Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004-2005, 2005-2006, and 2006-2007: a prospective study. Arch. Intern Med. 171, 151\u2013157 (2011).","journal-title":"Arch. Intern Med."},{"key":"1046_CR39","first-page":"52","volume":"4","author":"A Yassi","year":"1993","unstructured":"Yassi, A., McGill, M., Holton, D. & Nicolle, L. Morbidity, cost and role of health care worker transmission in an influenza outbreak in a tertiary care hospital. Can. J. Infect. Dis. 4, 52\u201356 (1993).","journal-title":"Can. J. Infect. Dis."},{"key":"1046_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02144-9","volume":"19","author":"P Kohler","year":"2021","unstructured":"Kohler, P. et al. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study. BMC Med 19, 270 (2021).","journal-title":"BMC Med"},{"key":"1046_CR41","doi-asserted-by":"publisher","unstructured":"Statistical code for multivariable models. Dryad digital data repository. https:\/\/doi.org\/10.5061\/dryad.v41ns1s88.","DOI":"10.5061\/dryad.v41ns1s88"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01046-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01046-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T22:47:32Z","timestamp":1757371652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01046-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01046-8","relation":{},"ISSN":["2730-664X"],"issn-type":[{"type":"electronic","value":"2730-664X"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Eastern Switzerland (#2020\u201300502).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"347"}}